Seller record · northlinelabs.org

Northline Labs

Fails 4 of 8 criteria. S1, prescriber requirement: No clinician appears anywhere on the site, and the research use agreement sells every product for in vitro laboratory research only. 3 more criteria also fail; see the table below.

At a glance

Northline Labsnorthlinelabs.org

4/8criteria passed
Price
Retatrutide from $79.99 for a 10 mg vial
Sells
retatrutide, research-grade semaglutide, research-grade tirzepatide, and 15 more
FDA letters
None on file
Visit Northline LabsSee all eight dispositions

Research vendor. Passes 4 of 8 criteria. Recorded against Standard v1.1.

A research peptide store selling retatrutide, semaglutide and tirzepatide under coded names such as Reta GLP-3, alongside about forty-five other compounds with an open cart. Its certificate archive links public reports from ILS Laboratories and Horizon Analytical, and no page names a company or an address.

Operating entity No legal entity name appears in the footer, on the contact page, in the terms or in the privacy policy.

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementFAILnorthlinelabs.org/ruo-agreement/
S2Prescription gatingFAILnorthlinelabs.org/product/reta-glp-3/
S3Pharmacy identificationFAILnorthlinelabs.org/terms-of-services/
S4Compounding disclosurePASSnorthlinelabs.org
S5Analytical documentationPASSnorthlinelabs.org/coas/
S6Business addressFAILnorthlinelabs.org/contact/
S7Price disclosurePASSnorthlinelabs.org/product/reta-glp-3/
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1FAILNo clinician appears anywhere on the site, and the research use agreement sells every product for in vitro laboratory research only.Source: northlinelabs.org/ruo-agreement/.
S2FAILProducts add to cart directly from the product page, and no eligibility step stands between the cart and checkout.Source: northlinelabs.org/product/reta-glp-3/.
S3FAILNo pharmacy is named anywhere on the site, and the terms describe every product as a research material rather than a drug.Source: northlinelabs.org/terms-of-services/.
S4PASSThe seller offers no compounded drug, and every page footer states that the products serve laboratory research only and are not for human consumption.Source: northlinelabs.org.
S5PASSThe certificate archive links a public ILS Laboratories certificate reporting 99.86 percent HPLC purity on retatrutide lot NLL-5525011, and other lots carry Horizon Analytical reports.Source: northlinelabs.org/coas/.
S6FAILNo street address appears on the footer, contact, terms or privacy pages, and the contact page offers only an email address and business hours.Source: northlinelabs.org/contact/.
S7PASSThe retatrutide page prints $79.99 for one 10 mg vial and the semaglutide page prints $44.99 for one 10 mg vial, with no account required to see either price.Source: northlinelabs.org/product/reta-glp-3/.
S8PASSNo FDA warning letter names Northline Labs, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: retatrutide, research-grade semaglutide, research-grade tirzepatide, cagrilintide, BPC-157, TB-500, GHK-Cu, NAD+, MOTS-c, PT-141, tesamorelin, ipamorelin, sermorelin, semax, epitalon, glutathione, KPV, peptide blends.

Unpaid link. Northline Labs does not pay the site, and nothing is earned when it is used. Funding.

Visit Northline Labs

127 sellers pass S1, prescriber requirement

Records dated August 2026

Records dated September 2026

See all 127 on the S1 criterion page — 119 more than shown here.

This seller fails criteria a medical service must meet. The records above belong to sellers that pass S1; some are partner links, disclosed on their records.

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.